vs

Side-by-side financial comparison of MANHATTAN ASSOCIATES INC (MANH) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $282.2M, roughly 1.1× MANHATTAN ASSOCIATES INC). MANHATTAN ASSOCIATES INC runs the higher net margin — 17.5% vs -18.2%, a 35.7% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 6.0%).

Computer Associates International, Inc., later CA, Inc., and CA Technologies, Inc., was an American multinational enterprise software developer and publisher that existed from 1976 to 2018. CA grew to rank as one of the largest independent software corporations in the world, and at one point was the second largest. The company created systems software that ran in IBM mainframe, distributed computing, virtual machine, and cloud computing environments.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

MANH vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.1× larger
MDGL
$321.1M
$282.2M
MANH
Growing faster (revenue YoY)
MDGL
MDGL
+204.8% gap
MDGL
210.8%
6.0%
MANH
Higher net margin
MANH
MANH
35.7% more per $
MANH
17.5%
-18.2%
MDGL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MANH
MANH
MDGL
MDGL
Revenue
$282.2M
$321.1M
Net Profit
$49.3M
$-58.6M
Gross Margin
Operating Margin
23.0%
-18.6%
Net Margin
17.5%
-18.2%
Revenue YoY
6.0%
210.8%
Net Profit YoY
-6.3%
1.4%
EPS (diluted)
$0.82
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MANH
MANH
MDGL
MDGL
Q1 26
$282.2M
Q4 25
$270.4M
$321.1M
Q3 25
$275.8M
$287.3M
Q2 25
$272.4M
$212.8M
Q1 25
$262.8M
$137.3M
Q4 24
$255.8M
$103.3M
Q3 24
$266.7M
$62.2M
Q2 24
$265.3M
Net Profit
MANH
MANH
MDGL
MDGL
Q1 26
$49.3M
Q4 25
$52.0M
$-58.6M
Q3 25
$58.6M
$-114.2M
Q2 25
$56.8M
$-42.3M
Q1 25
$52.6M
$-73.2M
Q4 24
$48.0M
$-59.4M
Q3 24
$63.8M
$-107.0M
Q2 24
$52.8M
Gross Margin
MANH
MANH
MDGL
MDGL
Q1 26
Q4 25
55.0%
Q3 25
56.6%
Q2 25
57.3%
Q1 25
56.4%
96.7%
Q4 24
55.8%
Q3 24
55.5%
Q2 24
54.8%
Operating Margin
MANH
MANH
MDGL
MDGL
Q1 26
23.0%
Q4 25
24.8%
-18.6%
Q3 25
27.5%
-39.7%
Q2 25
27.1%
-22.2%
Q1 25
24.0%
-57.8%
Q4 24
23.7%
-64.8%
Q3 24
28.2%
-187.1%
Q2 24
25.7%
Net Margin
MANH
MANH
MDGL
MDGL
Q1 26
17.5%
Q4 25
19.2%
-18.2%
Q3 25
21.3%
-39.8%
Q2 25
20.8%
-19.9%
Q1 25
20.0%
-53.4%
Q4 24
18.8%
-57.5%
Q3 24
23.9%
-172.0%
Q2 24
19.9%
EPS (diluted)
MANH
MANH
MDGL
MDGL
Q1 26
$0.82
Q4 25
$0.86
$-2.55
Q3 25
$0.96
$-5.08
Q2 25
$0.93
$-1.90
Q1 25
$0.85
$-3.32
Q4 24
$0.77
$-2.50
Q3 24
$1.03
$-4.92
Q2 24
$0.85

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MANH
MANH
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$226.1M
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$205.2M
$602.7M
Total Assets
$740.5M
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MANH
MANH
MDGL
MDGL
Q1 26
$226.1M
Q4 25
$328.7M
$198.7M
Q3 25
$263.6M
$295.7M
Q2 25
$230.6M
$186.2M
Q1 25
$205.9M
$183.6M
Q4 24
$266.2M
$100.0M
Q3 24
$215.0M
$232.7M
Q2 24
$202.7M
Total Debt
MANH
MANH
MDGL
MDGL
Q1 26
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$117.6M
Q3 24
$117.1M
Q2 24
Stockholders' Equity
MANH
MANH
MDGL
MDGL
Q1 26
$205.2M
Q4 25
$314.8M
$602.7M
Q3 25
$309.2M
$625.7M
Q2 25
$278.8M
$696.0M
Q1 25
$245.1M
$710.6M
Q4 24
$299.1M
$754.4M
Q3 24
$278.0M
$777.2M
Q2 24
$240.6M
Total Assets
MANH
MANH
MDGL
MDGL
Q1 26
$740.5M
Q4 25
$839.4M
$1.3B
Q3 25
$768.8M
$1.4B
Q2 25
$744.7M
$1.0B
Q1 25
$708.2M
$996.6M
Q4 24
$757.6M
$1.0B
Q3 24
$698.1M
$1.1B
Q2 24
$665.3M
Debt / Equity
MANH
MANH
MDGL
MDGL
Q1 26
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.16×
Q3 24
0.15×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MANH
MANH
MDGL
MDGL
Operating Cash FlowLast quarter
$84.0M
$-133.5M
Free Cash FlowOCF − Capex
$-133.8M
FCF MarginFCF / Revenue
-41.7%
Capex IntensityCapex / Revenue
0.3%
0.1%
Cash ConversionOCF / Net Profit
1.70×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MANH
MANH
MDGL
MDGL
Q1 26
$84.0M
Q4 25
$147.1M
$-133.5M
Q3 25
$93.1M
$79.8M
Q2 25
$74.0M
$-47.1M
Q1 25
$75.3M
$-88.9M
Q4 24
$104.7M
$-104.5M
Q3 24
$62.3M
$-67.0M
Q2 24
$73.3M
Free Cash Flow
MANH
MANH
MDGL
MDGL
Q1 26
Q4 25
$142.4M
$-133.8M
Q3 25
$87.2M
$79.0M
Q2 25
$70.1M
Q1 25
$74.4M
Q4 24
$101.6M
$-104.7M
Q3 24
$61.3M
$-67.8M
Q2 24
$71.0M
FCF Margin
MANH
MANH
MDGL
MDGL
Q1 26
Q4 25
52.7%
-41.7%
Q3 25
31.6%
27.5%
Q2 25
25.7%
Q1 25
28.3%
Q4 24
39.7%
-101.3%
Q3 24
23.0%
-109.0%
Q2 24
26.8%
Capex Intensity
MANH
MANH
MDGL
MDGL
Q1 26
0.3%
Q4 25
1.7%
0.1%
Q3 25
2.1%
0.3%
Q2 25
1.5%
0.0%
Q1 25
0.3%
0.0%
Q4 24
1.2%
0.2%
Q3 24
0.4%
1.3%
Q2 24
0.8%
Cash Conversion
MANH
MANH
MDGL
MDGL
Q1 26
1.70×
Q4 25
2.83×
Q3 25
1.59×
Q2 25
1.30×
Q1 25
1.43×
Q4 24
2.18×
Q3 24
0.98×
Q2 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MANH
MANH

Services$125.7M45%
Cloud subscriptions$117.1M42%
Maintenance$30.6M11%
Hardware$6.5M2%
Software license$2.2M1%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons